AstraZeneca says its coronavirus vaccine 76% effective in US phase-3 trial ...Middle East

Business Standard - News
AstraZeneca says its coronavirus vaccine 76% effective in US phase-3 trial
This new efficacy analysis included the accrual of 190 symptomatic cases of Covid-19

Hence then, the article about astrazeneca says its coronavirus vaccine 76 effective in us phase 3 trial was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca says its coronavirus vaccine 76% effective in US phase-3 trial )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News